
Join to View Full Profile
20 Hospital DriveSuite 12Toms River, NJ 08755
Phone+1 732-244-2299
Fax+1 732-244-5757
Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Richmond University Medical CenterResidency, Psychiatry, 1983 - 1986
Kasturba Medical College ManipalClass of 1979
Certifications & Licensure
NJ State Medical License 1985 - 2027
NY State Medical License 1987 - 2023
GA State Medical License 1984 - 1995
American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification GlaceEMR, Glenwood Systems LLC, 2012-2017
- CMS Meaningful Use Stage 1 Certification GlaceEMR, Glenwood Systems LLC, 2012-2017
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2013 Jun 27
- A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease Start of enrollment: 2016 Jun 01
- Open-label Trial in Parkinson's Disease (PD) Start of enrollment: 2021 Feb 24
Publications & Presentations
PubMed
- 3 citationsANK3 as a Novel Genetic Biomarker for Liafensine in Treatment-Resistant Depression: The ENLIGHTEN Randomized Clinical Trial.Gang Wang, Mario Aguado, Matthew A Spear, Larry Alphs, Crystal Chen
JAMA Psychiatry. 2025-12-01 - 5 citationsPreclinical and clinical evaluation of LY3451838, a PACAP-neutralizing monoclonal antibody, in randomized, double-blind, placebo-controlled phase 1 and phase 2 studies...Michael P Johnson, Judith Krikke-Workel, Chetan N Patel, S Michelle Morin, P Kellie Turner
Cephalalgia. 2025-08-01 - 14 citationsSafety and Tolerability of GRF6019 Infusions in Severe Alzheimer's Disease: A Phase II Double-Blind Placebo-Controlled Trial.Jonas Hannestad, Tiffanie Duclos, Whitney Chao, Katie Koborsi, Vicki Klutzaritz
Journal of Alzheimer's Disease. 2021-01-01
Professional Memberships
- Member
Other Languages
- Swahili
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









